|
1
|
Ebina Y, Mikami M, Nagase S, Tabata T,
Kaneuchi M, Tashiro H, Mandai M, Enomoto T, Kobayashi Y, Katabuchi
H, et al: Japan society of gynecologic oncology guidelines 2017 for
the treatment of uterine cervical cancer. Int J Clin Oncol.
24:1–19. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Koh W, Abu-Rustum NR, Bean S, Bradley K,
Campos SM, Cho KR, Chon HS, Chu C, Clark R, Cohn D, et al: Cervical
cancer, version 3.2019, NCCN clinical practice guidelines in
oncology. J Natl Compr Canc Netw. 17:64–84. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Reed N, Balega J, Barwick T, Buckley L,
Burton K, Eminowicz G, Forrest J, Ganesan R, Harrand R, Holland C,
et al: British gynaecological cancer society (BGCS) cervical cancer
guidelines: Recommendations for practice. Eur J Obstet Gynecol
Reprod Biol. 256:433–465. 2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Delgado G, Bundy B, Zaino R, Sevin BU,
Creasman WT and Major F: Prospective surgical-pathological study of
disease-free interval in patients with stage IB squamous cell
carcinoma of the cervix: A gynecologic oncology group study.
Gynecol Oncol. 38:352–357. 1990.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kridelka FJ, Berg DO, Neuman M, Edwards
LS, Robertson G, Grant PT and Hacker NF: Adjuvant small field
pelvic radiation for patients with high risk, stage IB lymph node
negative cervix carcinoma after radical hysterectomy and pelvic
lymph node dissection. A pilot study. Cancer. 86:2059–2065.
1999.PubMed/NCBI
|
|
6
|
Querleu D and Morrow CP: Classification of
radical hysterectomy. Lancet Oncol. 9:297–303. 2008.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chino J, Annunziata CM, Beriwal S,
Bradfield L, Erickson BA, Fields EC, Fitch K, Harkenrider MM,
Holschneider CH, Kamrava M, et al: Radiation therapy for cervical
cancer: Executive summary of an ASTRO clinical practice guideline.
Pract Radiat Oncol. 10:220–234. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR’ for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Yahata H, Sonoda K, Inoue S, Yasutake N,
Kodama K, Yagi H, Yasunaga M, Ohgami T, Onoyama I, Kaneki E, et al:
Is adjuvant therapy necessary for patients with intermediate-risk
cervical cancer after open radical hysterectomy? Oncology.
98:853–858. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kim K, Kang SB, Chung HH, Kim JW, Park NH
and Song YS: Comparison of chemoradiation with radiation as
postoperative adjuvant therapy in cervical cancer patients with
intermediate-risk factors. Eur J Surg Oncol. 35:192–196.
2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Cibula D, Abu-Rustum NR, Fischerova D,
Pather S, Lavigne K, Slama J, Alektiar K, Ming-Yin L, Kocian R,
Germanova A, et al: Surgical treatment of ‘intermediate risk’ lymph
node negative cervical cancer patients without adjuvant
radiotherapy-A retrospective cohort study and review of the
literature. Gynecol Oncol. 151:438–443. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sedlis A, Bundy BN, Rotman MZ, Lentz SS,
Muderspach LI and Zaino RJ: A randomized trial of pelvic radiation
therapy versus no further therapy in selected patients with stage
IB carcinoma of the cervix after radical hysterectomy and pelvic
lymphadenectomy: A gynecologic oncology group study. Gynecol Oncol.
73:177–183. 1999.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Rotman M, Sedlis A, Piedmonte MR, Bundy B,
Lentz SS, Muderspach LI and Zaino RJ: A phase III randomized trial
of postoperative pelvic irradiation in stage IB cervical carcinoma
with poor prognostic features: Follow-up of a gynecologic oncology
group study. Int J Radiat Oncol Biol Phys. 65:169–176.
2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Cao L, Wen H, Feng Z, Han X, Zhu J and Wu
X: Role of adjuvant therapy after radical hysterectomy in
intermediate-risk, early-stage cervical cancer. Int J Gynecol
Cancer. 31:52–58. 2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Chu R, Zhang Y, Qiao X, Xie L, Chen W,
Zhao Y, Xu Y, Yuan Z, Liu X, Yin A, et al: Risk stratification of
early-stage cervical cancer with intermediate-risk factors: Model
development and validation based on machine learning algorithm.
Oncologist. 26:e2217–e2226. 2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yeo RM, Chia YN, Namuduri RP, Yap SP,
Soong YL, Yam PK, Lim TY and Khoo-Tan HS: Tailoring adjuvant
radiotherapy for stage IB-IIA node negative cervical carcinoma
after radical hysterectomy and pelvic lymph node dissection using
the GOG score. Gynecol Oncol. 123:225–229. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Nakamura K, Kitahara Y, Satoh T, Takei Y,
Takano M, Nagao S, Sekiguchi I and Suzuki M: Analysis of the effect
of adjuvant radiotherapy on outcomes and complications after
radical hysterectomy in FIGO stage IB1 cervical cancer patients
with intermediate risk factors (GOTIC study). World J Surg Oncol.
14(173)2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
National Comprehensive Cancer Network.
Cervical Cancer (version 4.2019). https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1426
(accessed September 2019).
|
|
19
|
Matsuo K, Shimada M, Yamaguchi S, Matoda
M, Nakanishi T, Kikkawa F, Ohmichi M, Okamoto A, Sugiyama T and
Mikami M: Association of radical hysterectomy surgical volume and
survival for early-stage cervical cancer. Obstet Gynecol.
133:1086–1098. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Takeda N, Sakuragi N, Takeda M, Okamoto K,
Kuwabara M, Negishi H, Oikawa M, Yamamoto R, Yamada H and Fujimoto
S: Multivariate analysis of histopathologic prognostic factors for
invasive cervical cancer treated with radical hysterectomy and
systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol
Scand. 81:1144–1151. 2002.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Biewenga P, van der Velden J, Mol BW,
Stalpers LJ, Schilthuis MS, van der Steeg JW, Burger MP and Buist
MR: Prognostic model for survival in patients with early stage
cervical cancer. Cancer. 117:768–776. 2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yoneoka Y, Kato MK, Tanase Y, Uno M,
Ishikawa M, Murakami T and Kato T: The baseline recurrence risk of
patients with intermediate-risk cervical cancer. Obstet Gynecol
Sci. 64:226–233. 2021.PubMed/NCBI View Article : Google Scholar
|
